Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy
← catalyst calendarSponsored by Pfizer (industry) · PFE — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
114actual
Sites
53
Countries
Australia, Belgium, Canada +12
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-11-05 | actual | When the study began enrolling |
| Primary completion | 2024-05-15 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2039-04-15 | estimated | The whole study's end, after follow-up |
| First posted | 2020-02-24 | actual | When this record first appeared on the registry |
| Results posted | 2025-06-08 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-07-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Duchenne Muscular Dystrophy
Interventions
- Genetic: PF-06939926
- Other: Placebo
- Other: Placebo
- Genetic: PF-06939926
Primary outcome
what the primary-completion date above is the date OFChange From Baseline in North Star Ambulatory Assessment (NSAA) Total Score at Week 52
measured Baseline, Week 52
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2023-12-28 · 4.1 MB · Prot_000.pdf
Statistical Analysis Planposted 2024-04-08 · 733 KB · SAP_001.pdf
Publications
- PMID 41722591 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed